Study of patients with nonvalvular atrial fibrillation (NVAF) who are newly prescribed NOACs (Novel Oral Anticoagulants) in routine clinical practice in England
Study Type
OBSERVATIONAL
Non-interventional
Non-Interventional
Local Institution
Bethesda, Maryland, United States
Incidence of major bleeding
Time frame: At the end of 1 year
Incidence of intracranial bleeding
Time frame: At the end of 1 year
Incidence of gastrointestinal bleeding
Time frame: At the end of 1 year
Incidence of clinically relevant non-major bleeding
Time frame: At the end of 1 year
Incidence of ischemic stroke
Time frame: At the end of 1 year
Incidence of unspecified stroke
Time frame: At the end of 1 year
Incidence of systemic embolic events
Time frame: At the end of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.